Publications in collaboration with researchers from University Medical Center Freiburg (8)

2011

  1. Development of an LC-MS/MS method for the quantitation of 55 compounds prescribed in combined cardiovascular therapy

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 879, Núm. 3-4, pp. 243-252

2010

  1. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 878, Núm. 28, pp. 2685-2692

2009

  1. Optimization and validation of a SPE-HPLC-PDA-fluorescence method for the simultaneous determination of drugs used in combined cardiovascular therapy in human plasma

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 50, Núm. 4, pp. 630-639

  2. Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, Núm. 27, pp. 3045-3053

2007

  1. Hydrolysis and transesterification reactions of candesartan cilexetil observed during the solid phase extraction procedure

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 855, Núm. 2 SPEC. ISS., pp. 134-138

  2. Validated quantitation of angiotensin II receptor antagonists (ARA-II) in human plasma by liquid-chromatography-tandem mass spectrometry using minimum sample clean-up and investigation of ion suppression

    Therapeutic Drug Monitoring, Vol. 29, Núm. 6, pp. 824-834

2006

  1. Instability of calcium channel antagonists during sample preparation for LC-MS-MS analysis of serum samples

    Forensic Science International, Vol. 156, Núm. 1, pp. 23-34

2005

  1. Quantitative determination of the calcium channel antagonists amlodipine, lercanidipine, nitrendipine, felodipine, and lacidipine in human plasma using liquid chromatography-tandem mass spectrometry

    Therapeutic Drug Monitoring, Vol. 27, Núm. 1, pp. 44-52